FDA grants emergency authorization to two blood purification systems

This post was originally published on this site

The Food and Drug Administration (FDA) on Friday issued emergency use authorizations to blood purification devices manufactured by Terumo Corp. 4543, +0.13% and Marker Therapeutics Inc. MRKR, +1.74% in response to the COVID-19 pandemic.

Click here to read full article